Biotech Investing

Q BioMed 'looking for a significant return for shareholders' – CEO Denis Corin

Biotech Investing

Biotech Investing

Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements. ”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, …

Denis Corin, chief executive of Q BioMed Inc. (OTCQB:QBIO) ) tells Proactive’s Andrew Scott their objective is to find innovative, under-valued and under-appreciated biotech assets out in the pharma world and bring them in-house through licensing and option agreements.
”[We’re] agnostic in terms of exit …. as long as there’s a significant return for shareholders”, Corin says.

Watch Full Interview here

Click here to connect with Q BioMed Inc. (OTCQB:QBIO) to receive an Investor Presentation.

Source: www.proactiveinvestors.com

Biotech Investing